Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Attention Deficit – unable to pay attention, easily distracted

This Clinical Trial is looking for adults ages 18-55 with moderate to severe attention-deficit hyperactivity disorder (ADHD).

Patients must have

  1. Significant problems with inattention and/or hyperactivity/impulsivity.

Patients must not have

  1. Other significant medical or psychiatric disorders.
  2. Bipolar disorder, schizophrenia, or other psychotic disorder.
  3. Severe obesity (BMI greater than or equal to 39).
  4. Seizure disorder.
  5. Hypertension that is not controlled with treatment.
  6. Untreated thyroid disease.
  7. Tourette’s disorder or tics.
  8. Significant heart problems.
  9. Current use of any psychiatric medicines other than stimulants.
  10. Poor response in the past to amphetamines or methylphenidate taken in sufficient doses.
  11. Drug or alcohol abuse.
  12. Current use of street drugs with inability to stay off them.

The new medicine being used is a form of amphetamine.

See if you qualify. Please contact:

Call our office at 586-254-0707, or fill out a request for us to contact you.

Located in the Detroit metro area, Dr. Sangal of Sleep and Attention Disorders Institute sees patients from all over SE Michigan. Patients see him from communities like Warren, Shelby, Sterling Heights, Rochester Hills, Madison Heights, and Troy. Dr. Sangal is experienced in working with attention deficit disorders.

We treat every patient and clinical trial participant with respect, concern and consideration. To learn more about how you may participate in this study, please contact:

Sleep & Attention Disorders Institute

586-254-0707

44344 Dequindre Rd Suite 360

Sterling Heights, MI 48314

Coronavirus Covid-19 Sleep and Attention Disorders Institute Response

Coronavirus Covid-19 Sleep and Attention Disorders Institute Response By March 20, 2020, Michigan had become a Covid-19 moderately impacted state. Here is the Coronavirus Covid-19 Sleep and Attention Disorders Institute Response. As Covid-19 began to spread across the USA, we started paying even more attention to hygiene. We have always been very aware of the…

Pitolisant, a new medicine for excessive sleepiness in narcolepsy

Pitolisant, a new medicine for excessive sleepiness in narcolepsy   Pitolisant is a new medicine approved by the FDA for treatment of excessive sleepiness in narcolepsy. It is an H3 reverse agonist. That means that it reduces activity at the Histamine 3 receptor in the brain. Histamine is one of the brain chemicals that helps…

Do Sleep Medicine dcotors edit the tech’s scoring?

Do Sleep Medicine doctors edit the tech’s scoring? Overheard at an airline lounge as three gentlemen were talking while waiting for their flight after a Sleep Medicine annual meeting: Physician 1: Do you guys edit or change anything the techs have done when you review sleep testing records? Physician 2: Our software only allows me…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions